Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Venous Thrombosis 1Rectal Neoplasms 1Pulmonary Embolism 1Neuralgia 1Cancer Pain 1Agnosia 1

Interventions

Dalteparin 11apixaban 9Enoxaparin 7edoxaban 5Tinzaparin 5Rivaroxaban 4Heparin, Low-Molecular-Weight 4Dabigatran 3bemiparin 2abelacimab 2Warfarin 2Nadroparin 2MAA868 2Fondaparinux 2reviparin 1myotubularin 1isoquercitrin 1certoparin 1atezolizumab 1acarboxyprothrombin 1Ultrasonography, Doppler, Duplex 1Rosuvastatin Calcium 1Phenprocoumon 1Models, Biological 1Medication Therapy Management 1Intermittent Pneumatic Compression Devices 1Imaging, Three-Dimensional 1Hospitals 1Heparin 1Fluorodeoxyglucose F18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Venous Thrombosis × Hospitals × Clear all
NCT04158973 2021-08-03

CHIPs-VTE Study in Hospitalized Patients With Lung Cancer

China-Japan Friendship Hospital

Phase NA Unknown
3,200 enrolled

Pulmonary Embolism, Venous Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡